Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Migraine (Adult) Clinical Trials

A listing of Migraine (Adult) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (20) clinical trials

Migraine headaches are debilitating conditions which can interrupt your way of life. Wake Research Associates is enrolling volunteers in a study testing the effectiveness, tolerability and safety of an investigational medication. If you suffer from frequent migraine headaches, you may qualify.

Phase N/A

Dr. Craig LaForce and Dr. Karen Dunn are recruiting individuals 18-75 years old who have a diagnosis of Migraine headaches to participate in a research study involving an investigational medication.

Phase N/A

BHV-3000 versus placebo in Acute Migraine. The study will recruit male and female patients 18 years of age and older with at least a one-year history of migraines (with or without aura), consistent with a diagnosis according to the International Classification of Headache Disorders, including an age of onset prior ...

Phase

BHV-3000 versus placebo in Acute Migraine. The study will recruit male and female patients 18 years of age and older with at least a one-year history of migraines (with or without aura), consistent with a diagnosis according to the International Classification of Headache Disorders, including an age of onset prior ...

Phase

People with Acute Migraines are asked to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

This study will evaluate the safety and tolerability of the following doses of AGN-241689: 10 mg once daily (QD), 30 mg QD, 30 mg twice daily (BID), 60 mg QD, and 60 mg BID for the prevention of episodic migraine and will characterize the dose/response relationship.

Phase N/A

Efficacy, Tolerability, and Safety of DFN-15 in episodic migraine with or without aura, being conducted at multiple centers in the United States

Phase

The purpose of this study is to assess the efficacy and safety of ALD403 in the prevention of migraine headache in chronic migraineurs.

Phase N/A

Protocol #: 20150308 Migraine prevention in Subjects with Chronic Migraine (CM) or Episodic Migraine (EM) comparing the treatment medication AMG 301 to placebo.

Phase

Rimegepant is being developed for the treatment of migraine, with a specific focus on acute treatment. Effectiveness against migraine was demonstrated in a Phase 2b double-blind, randomized, placebocontrolled, dose-ranging study where rimegepant at 75 mg showed efficacy on all four traditional endpoints: pain, nausea, photophobia and phonophobia.

Phase